FlashDx Inc.

FlashDx is pleased to collaborate with Microbe&Lab BV, establishing them as our center of excellence for molecular diagnostics in the Netherlands. This collaboration will bring together FlashDx's expertise in near-patient molecular syndromic test with Microbe&Lab BV's established presence and advanced diagnostic solutions. This partnership will further improve patient care by providing accurate disease area syndromic tests. #FlashDx #FlashDxinAction #MicrobeAndLab #MolecularDiagnostics #SyndromicTest #Diagnostics #Netherlands #Healthcare

FlashDx is immensely proud to emerge victorious at this prestigious competition, and we extend our heartfelt gratitude to our exceptional team and the esteemed judges for their unwavering support and recognition. 🎊 #FlashDx #Respiratory #Diagnostics #SyndromicTest #PatientCare #sSPRT

Nataly, TM de Microbiología del Hospital Dr. Abraham Godoy Peña de Lautaro nos muestra el nuevo integrante de su equipo, FlashDx Inc. plataforma con la cual podrá dar diagnóstico molecular rápido, preciso y seguro a sus pacientes. Alatheia representante exclusivo de FlashDx Inc. en Chile

FlashDx molecular test platform in a Belgium hospital (AZ Sint-Lucas): "The FlashDx-1000-E platform with the Respiratory Panel 1.0 met our criteria for rapid and reliable respiratory syndromic diagnostics." Interested in learning more? Visit our website www.flash-dx.com or contact us at info@flash-dx.com to discover how the FlashDx 1000-E platform, our respiratory panels, and our entire Near-Patient Molecular Syndromic Testing Solutions can benefit your laboratory. Related Links (Page 12): https://lnkd.in/grX-skk4 #FlashDx #Respiratory #Diagnostics #RapidTesting #SyndromicTest #PatientCare #SPRT

See You at ADLM 2024! FlashDx is delighted to extend an invitation for you to join us at ADLM 2024 in Chicago (July 28th-August 1st). Visit us at Booth # 4355 to: Engage with our scientific team in detailed discussions about SPRT™ and its advantages for near-patient molecular syndromic testing. Explore our comprehensive portfolio of near-patient and laboratory-based molecular syndromic tests. Discover how FlashDx empowers healthcare professionals to improve patient care across diverse clinical settings through rapid and accurate diagnoses. #ADLM2024 #FlashDx #MolecularDiagnostics #SPRT #POCT #NearPatient #SyndromicTesting

We're pleased to share a successful week at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 2024 in Barcelona! The FlashDx team had valuable discussions with leading figures in clinical microbiology and infectious diseases. Our booth (D14-1) saw a constant flow of visitors interested in exploring our innovative near-patient molecular syndromic testing solutions powered by SPRT™ technology. A sincere thank you to everyone who stopped by for insightful conversations and demonstrations of how FlashDx is transforming point-of-care diagnostics. Stay informed! We'll be sharing more updates on SPRT™ advancements and its impact on patient care. #ECCMID2024 #FlashDx #Diagnostics #MolecularTesting #SyndromicTesting #PointOfCare #SPRT What were your key takeaways from ECCMID? Share your thoughts and experiences in the comments below!

The Southern Hemisphere influenza season is well underway, typically lasting from May to October. With increasing flu infections, it's still a good time to get vaccinated and protect yourself from potential complications. #Fluseason #PublicHealth #RespiratoryPathogens #RapidDiagnosis #RespiratoryInfection #Antibiotics #FlashDX #FlashDxInAction #Diagnostics

Whooping cough, a highly contagious respiratory illness, is making a worrying comeback globally. Europe and Asia have seen significant spikes, while the US experiences clusters in some areas. Early and accurate diagnosis through rapid molecular testing is crucial. Tests like the FlashDx Respiratory Panel (RP) 1.1 can identify whooping cough (Bordetella pertussis) and other pathogens within an hour, allowing doctors to provide timely treatment. #WhoopingCough #PublicHealth #RespiratoryPathogens #RapidDiagnosis #RespiratoryInfection #Antibiotics #FlashDX #FlashDxInAction #Diagnostics #StopWhoopingCough

FlashDx is delighted to extend an invitation for you to join us at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 2024, scheduled from April 27-30 in Barcelona, Spain. We cordially invite you to visit our booth (D14-1) to: - Engage with our scientific team and delve into detailed discussions about the advantages of FlashDx's SPRT™ technology for near-patient molecular syndromic testing. - Explore our comprehensive portfolio of near-patient molecular syndromic tests. - Discover how FlashDx's solutions can enhance patient care in various clinical settings through rapid and accurate syndromic molecular diagnoses. At ECCMID, we'll be showcasing our near-patient and lab molecular syndromic testing solutions, powered by our unique SPRT™ (semi-Solid Phase Real-Time PCR) technology. This technology facilitates efficient and precise sample-to-answer molecular testing, thereby aiding clinicians in making informed treatment decisions. Additionally, we are offering a personalized booth tour and demonstration. To secure your spot, please contact us at info@flash-dx.com or visit our website at www.flash-dx.com.

Great to see our partner MiLAB today at Medlab Middle East 2024, showcasing the FlashDx-1000-E, an innovative syndromic molecular diagnostic platform using semi-Solid Phase Real Time PCR (SPRT™) technology. Visit the booth Z7.M32 and experience this innovative technology firsthand! #medlabmiddleeast #MiLAB #FlashDx #FlashDx1000E #pointofcare #diagnostics #SPRT #FlashDxInAction